Canadian court upholds data exclusivity rules for innovators
This article was originally published in SRA
Executive Summary
The Canadian Federal Court has upheld the government’s enactment of data protection regulations that provide up to eight years of protection for innovative drugs and the possibility of a further six months if studies are conducted in the paediatric population1-3.